Avinger (AVGR - Free Report) closed the most recent trading day at $0.58, moving -0.62% from the previous trading session. This move lagged the S&P 500's daily loss of 0.21%. Elsewhere, the Dow lost 0.46%, while the tech-heavy Nasdaq lost 0.16%.
Coming into today, shares of the medical device maker had lost 39.53% in the past month. In that same time, the Medical sector lost 3.93%, while the S&P 500 gained 2.07%.
Investors will be hoping for strength from AVGR as it approaches its next earnings release.
Any recent changes to analyst estimates for AVGR should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 23.64% higher. AVGR is currently a Zacks Rank #2 (Buy).
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 149, putting it in the bottom 42% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow AVGR in the coming trading sessions, be sure to utilize Zacks.com.